Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AMST
AMST logo

AMST Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
1.069
Open
1.060
VWAP
1.03
Vol
370.89K
Mkt Cap
5.53M
Low
0.973
Amount
382.31K
EV/EBITDA(TTM)
--
Total Shares
5.27M
EV
4.37M
EV/OCF(TTM)
--
P/S(TTM)
16.15
Amesite Inc. is a technology company. The Company focused on building and commercializing AI-powered solutions for the healthcare sector. The Company specializes in the development and marketing of business-to-consumer (B2C) and business-to-business (B2B) artificial intelligence (AI)-driven solutions, including its higher ed platform that offers professional learning. The Company's platform utilizes infrastructure to deliver both Amesite Engage for higher education and NurseMagic for healthcare. NurseMagic is a mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. NurseMagic is designed for use across various healthcare modalities, such as skilled nursing, assisted living, memory care, home health, and rehabilitation centers.
Show More

Events Timeline

(ET)
2026-04-27
12:40:00
Amesite Issues 696,866 Shares at $1.435 Each
select
2026-04-27
11:20:00
X-energy and Yesway Show Strong Debut Performance
select
2026-04-27
09:40:00
Amesite Files for Withdrawal of S-1 Registration Statement
select
2026-04-20 (ET)
2026-04-20
16:10:00
Benchmark Acts as Underwriter for This Offering
select
2026-03-26 (ET)
2026-03-26
10:50:00
Amesite Enters Trading Agreement with Homecare Tech Platform
select
2025-12-19 (ET)
2025-12-19
06:40:00
Amesite Launches NurseMagic EMR to Expand Platform
select
2025-09-11 (ET)
2025-09-11
06:32:07
Amesite Announces 63% Revenue Increase from NurseMagic Enterprise
select
2025-05-16 (ET)
2025-05-16
06:31:51
Amesite says flagship app NurseMagic generated 2.4x revenue from Q2 to Q3
select
2025-04-22 (ET)
2025-04-22
06:33:50
Amesite says NurseMagic now meets HIPAA requirements for all users
select
2025-04-04 (ET)
2025-04-04
18:19:52
Amesite says operations remain unaffected by recently announced U.S. tariffs
select

News

Newsfilter
8.5
04-28Newsfilter
Amesite Closes Private Placement of 696,866 Shares
  • Private Placement Completed: Amesite Inc. successfully closed a private placement of 696,866 shares of common stock at a price of $1.435 per share, expected to generate approximately $2.6 million in gross proceeds, thereby strengthening its capital base for future growth.
  • Warrants Issued: The placement included unregistered Series A-1 and A-2 warrants, each allowing the purchase of 696,866 shares at an exercise price of $1.435 per share, with potential additional gross proceeds of approximately $5.2 million if fully exercised.
  • Insider Participation: Company executives and board members participated in an insider-led private placement at a premium to market, involving 418,118 shares and corresponding warrants, reflecting management's confidence in the company's future prospects.
  • Compliance and Registration: The placement was conducted in accordance with Nasdaq rules and under a registered S-3 filing with the SEC, ensuring compliance and laying the groundwork for future capital operations.
Newsfilter
8.5
04-27Newsfilter
Amesite Inc. Completes Sale of 696,866 Shares in Direct Offering
  • Stock Offering Details: Amesite Inc. announced the issuance of 696,866 shares of common stock at a price of $1.435 per share, with expected gross proceeds of approximately $2 million, reflecting the company's active engagement in capital markets and financing capabilities.
  • Warrant Issuance: The company will also issue unregistered Series A-1 and A-2 warrants to investors, each allowing the purchase of 696,866 shares at the same exercise price of $1.435, enhancing future financing flexibility.
  • Use of Proceeds: The net proceeds from this offering will be allocated for general corporate purposes, including working capital, indicating the company's strategic intent to expand operations and improve efficiency.
  • Market Reaction Expectations: Although there is uncertainty regarding the exercise of the warrants, if fully exercised, they could generate an additional approximately $4 million for the company, further supporting its innovative developments in the healthcare sector.
Newsfilter
8.5
04-27Newsfilter
Amesite Withdraws Public Offering Registration Statement
  • Withdrawal of Registration Statement: On April 27, 2026, Amesite Inc. filed a request with the SEC to withdraw its S-1 registration statement originally submitted on April 20, 2026, indicating a significant strategic shift as the company no longer intends to pursue a public offering.
  • No Securities Sold: The registration statement has not been declared effective by the SEC, and no securities have been sold in connection with the offering, highlighting potential challenges in the company's financing strategy that may impact future capital operations.
  • Core Product Advantage: Amesite's flagship product, NurseMagic™, reduces documentation time for nurses and caregivers from 20 minutes to just 20 seconds, enhancing operational efficiency and is utilized by over 100 professions across 50 states and 21 countries, showcasing its market potential.
  • Market Positioning and Compliance: Built on proprietary AI trained on industry-specific data, NurseMagic™ meets HIPAA regulations while improving accuracy and efficiency, indicating the company's strong competitive edge and compliance capabilities in the healthcare sector.
Newsfilter
2.0
03-26Newsfilter
Amesite Partners with Homecare Tech Platform for NurseMagic Integration
  • Strategic Partnership Agreement: Amesite Inc. has signed an Electronic Transactions Trading Partner Agreement with a leading homecare technology platform, establishing itself as a compliant trading partner, which is expected to enhance the application of its AI platform NurseMagic™ in the non-acute care market, valued at approximately $1.55 trillion.
  • Integration Advantages: By connecting with this platform, NurseMagic™ can streamline electronic visit verification (EVV) processes using standardized formats mandated by CMS and the 21st Century Cures Act, thereby improving compliance efficiency and operational convenience for clients.
  • Revenue Growth Momentum: Amesite achieved a 69% quarter-over-quarter revenue increase in Q2 2026, with a 63% revenue growth following the launch of its census-based enterprise subscription model, indicating strong growth potential in the non-acute care market.
  • Industry Recognition: NurseMagic™ was named a finalist for Nurse.org's
Newsfilter
8.5
03-04Newsfilter
Amesite's NurseMagic™ Nominated for Best AI Nursing Tool
  • Industry Recognition: Amesite's AI healthcare platform, NurseMagic™, has been nominated as a finalist in the AI Nursing Tool category of Nurse.org's 'Best of Nursing Awards', highlighting its impact and credibility in the healthcare sector, thereby enhancing the company's competitive position in the estimated $460–510 billion U.S. post-acute care market.
  • Significant Revenue Growth: Following the launch of NurseMagic™ Teams+ in May 2025, the company reported a 2.4x quarter-over-quarter revenue increase, with an 82% revenue growth in the subsequent quarter after launching the enterprise tier, and a further 69% increase in the following period, indicating strong market demand and profitability.
  • User-Driven Expansion: By prioritizing service to nurses and caregivers, NurseMagic™ rapidly scaled across all 50 states and over 20 countries, establishing an engaged user community that not only validated the product's effectiveness in clinical workflows but also laid the groundwork for enterprise sales.
  • Technological Innovation and Market Potential: The AI-native EMR system of NurseMagic™ is designed to coexist with or replace legacy systems, expected to drive double-digit annual growth in the long-term care and post-acute software market, further solidifying Amesite's market share in this rapidly growing sector.
Benzinga
8.5
2025-12-22Benzinga
Clearwater Analytics (CWAN) Acquired by Private Equity Consortium for $8.4 Billion
  • Acquisition Announcement: A consortium of private equity firms led by Permira and Warburg Pincus has announced a deal to acquire Clearwater Analytics for approximately $8.4 billion, including debt, indicating strong market interest in investment and accounting software companies.
  • Stock Price Reaction: Clearwater Analytics shares surged 7.6% to $23.93 in pre-market trading, reflecting positive investor sentiment regarding the acquisition news, which may enhance the company's future market performance.
  • Market Impact: This acquisition not only provides Clearwater Analytics with financial backing but also has the potential to accelerate its technological innovation and market expansion, strengthening its position in the highly competitive software industry.
  • Industry Trend: With private equity firms continuing to invest in the software sector, more similar transactions are expected, further consolidating market resources and enhancing industry competitiveness.

Valuation Metrics

The current forward P/E ratio for Amesite Inc (AMST.O) is 0.00, compared to its 5-year average forward P/E of -4.53. For a more detailed relative valuation and DCF analysis to assess Amesite Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-4.53
Current PE
0.00
Overvalued PE
5.57
Undervalued PE
-14.63

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-5.75
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
14.73
Undervalued EV/EBITDA
-26.23

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
3.60
Current PS
0.00
Overvalued PS
9.87
Undervalued PS
-2.66

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

Stocks most likely to squeeze soon
Intellectia · 11 candidates
Region: USRelative Vol: >= 1.20Short Ratio: MoreThan30PctList Exchange: XNYS, XNAS, XASEWeek Price Change Pct: >= $5.00Floating Shares: <= 150,000,000
Ticker
Name
Market Cap$
top bottom
BRAG logo
BRAG
Bragg Gaming Group Inc
50.90M
CHNR logo
CHNR
China Natural Resources Inc
5.48M
APM logo
APM
Aptorum Group Ltd
7.63M
SLE logo
SLE
Super League Enterprise Inc
4.53M
STIM logo
STIM
Neuronetics Inc
104.95M
ARAY logo
ARAY
Accuray Inc
51.14M
predict most bullish ticker this month
Intellectia · 114 candidates
Rsi Category: moderateMoving Average Relationship: PriceAboveMA20, PriceAboveMA200One Month Rise Prob: >= 65One Month Predict Return: >= 10.0%
Ticker
Name
Market Cap$
top bottom
SPKL logo
SPKL
Spark I Acquisition Corp
98.18M
APXT logo
APXT
Apex Treasury Corp
458.22M
AMST logo
AMST
Amesite Inc
8.37M
CZFS logo
CZFS
Citizens Financial Services Inc
278.29M
JNJ logo
JNJ
Johnson & Johnson
571.52B
CRBU logo
CRBU
Caribou Biosciences Inc
184.58M

Whales Holding AMST

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Amesite Inc (AMST) stock price today?

The current price of AMST is 1.05 USD — it has decreased -3.67

What is Amesite Inc (AMST)'s business?

Amesite Inc. is a technology company. The Company focused on building and commercializing AI-powered solutions for the healthcare sector. The Company specializes in the development and marketing of business-to-consumer (B2C) and business-to-business (B2B) artificial intelligence (AI)-driven solutions, including its higher ed platform that offers professional learning. The Company's platform utilizes infrastructure to deliver both Amesite Engage for higher education and NurseMagic for healthcare. NurseMagic is a mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. NurseMagic is designed for use across various healthcare modalities, such as skilled nursing, assisted living, memory care, home health, and rehabilitation centers.

What is the price predicton of AMST Stock?

Wall Street analysts forecast AMST stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMST is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Amesite Inc (AMST)'s revenue for the last quarter?

Amesite Inc revenue for the last quarter amounts to 108.05K USD, increased 746.79

What is Amesite Inc (AMST)'s earnings per share (EPS) for the last quarter?

Amesite Inc. EPS for the last quarter amounts to -0.16 USD, decreased -60.00

How many employees does Amesite Inc (AMST). have?

Amesite Inc (AMST) has 6 emplpoyees as of May 04 2026.

What is Amesite Inc (AMST) market cap?

Today AMST has the market capitalization of 5.53M USD.